I thought with a couple of Insto's discussing positively (speculative buy ratings from both) on the big screen I thought the share price might at last "kicked on" as Josh Barker himself is surprised it hadn't following the BioHorizons deal (and now Ace too) that he rightly points out gives them 5 years to get cash positive, so not needing to raise - recent sales growth announcements, IF continued, suggest they will likely be cash flow positive by 2025. Perhaps that's just not quick enough for many investors in this monetary environment?
Perhaps I did Grady a bit of an injustice in my post above, when she got past pronouncing 'autologous' properly she at least points out their dominance in the area and the two nerve surgeons on the Board and fast track designation for Remplir in the US in 2024.
Sorry, digressing into market discussion on a media thread. For those who did not see OCC finally made it to financial media beyond the usual Proactive Investors, Stock-head and Market Herald, being on "The Call" on "Oz-biz" at 44 minutes:
https://******.com.au/media/the-call-thursday-28th-september?videoId=31971
Media thread, page-337
-
- There are more pages in this discussion • 251 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
-0.005(1.28%) |
Mkt cap ! $80.59M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.0¢ | 38.0¢ | $31.21K | 81.11K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 57705 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 1315 | 1 |
View Market Depth
| Last trade - 13.37pm 09/08/2024 (20 minute delay) ? |
| OCC (ASX) Chart |